Schedule 13G ownership disclosure
PIERIS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 720795103
Event date: 2016-06-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-16-004968
- Form type
- SC 13G
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Jun 17, 2016
- Reporting period
- Jun 08, 2016
- Description
- Schedule 13G beneficial ownership